Welsh Startup Antiverse Raises $2m for Antibody Discovery Toolkit
March 16, 2021
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies. The Cardiff, Wales startup is combining machine learning and phage display techniques to ...
chat_bubble0 Comment
visibility129 Views
Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform
March 15, 2021
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding totalling £1.4 million ($2 million USD), comprising new investment and match funding from the UKI2S Innovate Accelerator. The funding will ...
chat_bubble0 Comment
visibility190 Views
NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients
January 17, 2021
NHSX, a unit tasked with driving the digital transformation of care in the NHS, has brought together over 40,000 CT scans, MRIs and X-rays from more than 10,000 patients across the UK during the course ...
chat_bubble0 Comment
visibility219 Views
Popular Posts
